The soluble intracellular domain of megalin does not affect renal proximal tubular function in vivo

Annabel Christ1, Sara Terryn, Vanessa Schmidt

  • 1Max-Delbrück-Center for Molecular Medicine, Robert-Rössle-Strasse 10, Berlin, Germany.

Kidney International
|June 10, 2010
PubMed

Insights

The soluble intracellular domain of megalin does not regulate kidney function. This study found no distinct effects on renal proximal tubular function, including megalin expression or protein retrieval.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Cell Biology

Background:

  • Megalin is crucial for clearing plasma proteins in kidney proximal tubules via endocytosis.
  • Mechanisms controlling megalin expression and activity in the kidney remain largely unknown.
  • A hypothesis suggests megalin's cytosolic domain regulates its own gene transcription after release.

Purpose of the Study:

  • To investigate the role of the soluble intracellular domain of megalin in regulating renal proximal tubular function.
  • To test the hypothesis that the released cytosolic domain of megalin modulates its own gene transcription.

Main Methods:

  • Generation of a mouse model co-expressing soluble intracellular megalin and full-length megalin.
  • Assessment of renal proximal tubular function, megalin expression, and protein endocytic retrieval.
  • Analysis of global renal gene transcription in the generated mouse model.

Main Results:

  • The soluble intracellular megalin domain was synthesized but did not alter renal proximal tubular function.
  • No distinct effects were observed on megalin expression or the endocytic retrieval of proteins.
  • Global renal gene transcription remained unaffected by the presence of the soluble intracellular domain.

Conclusions:

  • The soluble intracellular domain of megalin does not appear to play a regulatory role in kidney proximal tubule function.
  • The proposed mechanism of intramembrane proteolysis followed by transcriptional regulation by the cytosolic domain is not supported by this study.
  • Further research is needed to elucidate the precise mechanisms controlling megalin activity in the kidney.

Related Concept Videos

Drug Elimination by Renal Route: Tubular Secretion01:15

Drug Elimination by Renal Route: Tubular Secretion

Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate01:25

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate

The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
Renal Drug Excretion: Tubular Secretion01:28

Renal Drug Excretion: Tubular Secretion

Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...